Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Skin Beneath (TSB) is an innovative biotechnology and medical device company focused on advancing skin health through subdermal monitoring and targeted delivery systems. The company develops specialized technologies designed to monitor physiological changes beneath the skin's surface and provide precise therapeutic interventions for wound care and dermatological conditions. By integrating advanced sensors with biocompatible materials, TSB aims to improve clinical outcomes for patients with chronic wounds and complex skin disorders. Their approach combines medical-grade diagnostics with therapeutic applications to bridge the gap between topical treatments and systemic medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Skin Beneath.